XML 58 R38.htm IDEA: XBRL DOCUMENT v3.3.1.900
Segment Reporting and Foreign Operations (Tables)
12 Months Ended
Dec. 31, 2015
Segment Reporting [Abstract]  
Revenue from External Customers by Products and Services
Listed below are the sales by business segment for the years ended December 31, 2015, 2014 and 2013 (in thousands):

 
% Change
 
2015
 
% Change
 
2014
 
% Change
 
2013
 
 
 
 
 
 
 
 
 
 
 
 
Cardiovascular
 

 
 

 
 

 
 

 
 

 
 

Stand-alone devices
8
%
 
$
155,414

 
15
%
 
$
143,712

 
10
 %
 
$
125,445

Custom kits and procedure trays
5
%
 
116,368

 
7
%
 
111,076

 
10
 %
 
103,700

Inflation devices
1
%
 
73,373

 
10
%
 
72,538

 
(4
)%
 
66,182

Catheters
11
%
 
96,833

 
17
%
 
87,550

 
16
 %
 
75,131

Embolization devices
3
%
 
45,025

 
31
%
 
43,855

 
(1
)%
 
33,395

CRM/EP
3
%
 
33,902

 
17
%
 
32,975

 
1,359
 %
 
28,271

Total
6
%
 
520,915

 
14
%
 
491,706

 
14
 %
 
432,124

 
 
 
 
 
 
 
 
 
 
 
 
Endoscopy
 

 
 

 
 

 
 

 
 

 
 

Endoscopy devices
18
%
 
21,234

 
6
%
 
17,983

 
7
 %
 
16,925

 
 
 
 
 
 
 
 
 
 
 
 
Total
6
%
 
$
542,149

 
14
%
 
$
509,689

 
14
 %
 
$
449,049

Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas
Our long-lived assets by geographic area at December 31, 2015, 2014 and 2013, consisted of the following (in thousands):

 
2015
 
2014
 
2013
United States
$
186,389

 
$
177,627

 
$
178,130

Ireland
48,896

 
49,708

 
50,274

Other foreign countries
32,493

 
16,836

 
14,866

Total
$
267,778

 
$
244,171

 
$
243,270

Schedule of Segment Reporting Information, by Segment
Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the years ended December 31, 2015, 2014 and 2013, are as follows (in thousands):

 
2015
 
2014
 
2013
Revenues
 

 
 

 
 

Cardiovascular
$
520,915

 
$
491,706

 
$
432,124

Endoscopy
21,234

 
17,983

 
16,925

Total revenues
542,149

 
509,689

 
449,049

 
 
 
 
 
 
Operating expenses
 

 
 

 
 

Cardiovascular
187,492

 
175,152

 
157,479

Endoscopy
10,746

 
9,904

 
9,044

Total operating expenses
198,238

 
185,056

 
166,523

 
 
 
 
 
 
Operating income (loss)
 

 
 

 
 

Cardiovascular
34,052

 
38,601

 
26,597

Endoscopy
3,491

 
1,565

 
1,247

Total operating income
37,543

 
40,166

 
27,844

 
 
 
 
 
 
Total other expense - net
(6,343
)
 
(8,594
)
 
(8,005
)
Income tax expense
7,398

 
8,598

 
3,269

 
 
 
 
 
 
Net income
$
23,802

 
$
22,974

 
$
16,570

Total depreciation and amortization by business segment for the years ended December 31, 2015, 2014 and 2013, consisted of the following (in thousands):

 
2015
 
2014
 
2013
 
 
 
 
 
 
Cardiovascular
$
36,474

 
$
34,975

 
$
31,594

Endoscopy
951

 
954

 
948

Total
$
37,425

 
$
35,929

 
$
32,542



Total capital expenditures for property and equipment by business segment for the years ended December 31, 2015, 2014 and 2013, consisted of the following (in thousands):

 
2015
 
2014
 
2013
 
 
 
 
 
 
Cardiovascular
$
50,927

 
$
33,660

 
$
59,421

Endoscopy
32

 
521

 
84

Total
$
50,959

 
$
34,181

 
$
59,505

Reconciliation of Assets from Segment to Consolidated
Total assets by business segment at December 31, 2015, 2014 and 2013, consisted of the following (in thousands):

 
2015
 
2014
 
2013
Cardiovascular
$
767,952

 
$
734,940

 
$
716,659

Endoscopy
10,776

 
12,225

 
11,624

Total
$
778,728

 
$
747,165

 
$
728,283